News

Be inspired. Stay up to date.

Regeneron announces 200 new jobs for Limerick by end 2017

Raheen site will be largest capacity biopharmaceutical production facility in Ireland

Limerick, Ireland (October 19, 2015) -- Regeneron Pharmaceuticals, Inc., (NASDAQ: REGN) a leading science-driven biopharmaceutical company, today announced that it is investing an additional $350 million in its Limerick Industrial Operations and Product Supply (IOPS) bioprocessing campus and will add another 200 jobs, bringing the total expected job creation in the Limerick area to 500 jobs and total investment to $650 million by the end of 2017.

The company acquired the former Dell Computer facility in Limerick and achieved planning approval in April 2014 for its first IOPS site outside of the United States. When the investment was initially announced in December 2013, a $300 million investment with 300 jobs was planned for delivery by the end of 2016. With this expansion of scope, the Limerick IOPS campus will house the largest-scale bulk biologics production facility in Ireland.